BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38511794)

  • 1. BEYOND TRADITIONAL TOOLS: EXPLORING CONVOLUTIONAL NEURAL NETWORKS AS INNOVATIVE PROGNOSTIC MODELS IN PANCREATIC DUCTAL ADENOCARCINOMA.
    Ahmed HS
    Arq Gastroenterol; 2024; 61():e23107. PubMed ID: 38511794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Transfer Learning Based Features in Resectable Pancreatic Ductal Adenocarcinoma.
    Zhang Y; Lobo-Mueller EM; Karanicolas P; Gallinger S; Haider MA; Khalvati F
    Front Artif Intell; 2020; 3():550890. PubMed ID: 33733206
    [No Abstract]   [Full Text] [Related]  

  • 3. CNN-based survival model for pancreatic ductal adenocarcinoma in medical imaging.
    Zhang Y; Lobo-Mueller EM; Karanicolas P; Gallinger S; Haider MA; Khalvati F
    BMC Med Imaging; 2020 Feb; 20(1):11. PubMed ID: 32013871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilisation of artificial intelligence for the development of an EUS-convolutional neural network model trained to enhance the diagnosis of autoimmune pancreatitis.
    Marya NB; Powers PD; Chari ST; Gleeson FC; Leggett CL; Abu Dayyeh BK; Chandrasekhara V; Iyer PG; Majumder S; Pearson RK; Petersen BT; Rajan E; Sawas T; Storm AC; Vege SS; Chen S; Long Z; Hough DM; Mara K; Levy MJ
    Gut; 2021 Jul; 70(7):1335-1344. PubMed ID: 33028668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic cancer, radiomics and artificial intelligence.
    Marti-Bonmati L; Cerdá-Alberich L; Pérez-Girbés A; Díaz Beveridge R; Montalvá Orón E; Pérez Rojas J; Alberich-Bayarri A
    Br J Radiol; 2022 Sep; 95(1137):20220072. PubMed ID: 35687700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Segmentation of pancreatic ductal adenocarcinoma (PDAC) and surrounding vessels in CT images using deep convolutional neural networks and texture descriptors.
    Mahmoudi T; Kouzahkanan ZM; Radmard AR; Kafieh R; Salehnia A; Davarpanah AH; Arabalibeik H; Ahmadian A
    Sci Rep; 2022 Feb; 12(1):3092. PubMed ID: 35197542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review study on early detection of pancreatic ductal adenocarcinoma using artificial intelligence assisted diagnostic methods.
    Sijithra PC; Santhi N; Ramasamy N
    Eur J Radiol; 2023 Sep; 166():110972. PubMed ID: 37454557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep Convolutional Neural Network-Assisted Feature Extraction for Diagnostic Discrimination and Feature Visualization in Pancreatic Ductal Adenocarcinoma (PDAC) versus Autoimmune Pancreatitis (AIP).
    Ziegelmayer S; Kaissis G; Harder F; Jungmann F; Müller T; Makowski M; Braren R
    J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33322559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep Learning in Pancreatic Tissue: Identification of Anatomical Structures, Pancreatic Intraepithelial Neoplasia, and Ductal Adenocarcinoma.
    Kriegsmann M; Kriegsmann K; Steinbuss G; Zgorzelski C; Kraft A; Gaida MM
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical issues in pathologic evaluation of pancreatic ductal adenocarcinoma resected after neoadjuvant treatment: a narrative review.
    Taherian M; Wang H
    Chin Clin Oncol; 2022 Jun; 11(3):21. PubMed ID: 35726190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of glycolysis-related prognostic score for prediction of prognosis and chemosensitivity of pancreatic ductal adenocarcinoma.
    Zhang XP; Chen Q; Liu Q; Wang Y; Wang F; Zhao ZM; Zhao GD; Lau WY; Gao YZ; Liu R
    J Cell Mol Med; 2021 Jun; 25(12):5615-5627. PubMed ID: 33942483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A deep learning model using hyperspectral image for EUS-FNA cytology diagnosis in pancreatic ductal adenocarcinoma.
    Qin X; Zhang M; Zhou C; Ran T; Pan Y; Deng Y; Xie X; Zhang Y; Gong T; Zhang B; Zhang L; Wang Y; Li Q; Wang D; Gao L; Zou D
    Cancer Med; 2023 Aug; 12(16):17005-17017. PubMed ID: 37455599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial intelligence and imaging for risk prediction of pancreatic cancer: a narrative review.
    Qureshi TA; Javed S; Sarmadi T; Pandol SJ; Li D
    Chin Clin Oncol; 2022 Feb; 11(1):1. PubMed ID: 35144387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of Prognostic Radiomic Features From Resectable Pancreatic Ductal Adenocarcinoma in Patients With Advanced Disease Undergoing Chemotherapy.
    Salinas-Miranda E; Khalvati F; Namdar K; Deniffel D; Dong X; Abbas E; Wilson JM; O'Kane GM; Knox J; Gallinger S; Haider MA
    Can Assoc Radiol J; 2021 Nov; 72(4):605-613. PubMed ID: 33151087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of laminin γ2 as a prognostic and predictive biomarker for determining response to gemcitabine-based therapy in pancreatic ductal adenocarcinoma.
    Okada Y; Nishiwada S; Yamamura K; Sho M; Baba H; Takayama T; Goel A
    Eur J Cancer; 2021 Mar; 146():125-134. PubMed ID: 33607476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune cell infiltrates as prognostic biomarkers in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis.
    McGuigan AJ; Coleman HG; McCain RS; Kelly PJ; Johnston DI; Taylor MA; Turkington RC
    J Pathol Clin Res; 2021 Mar; 7(2):99-112. PubMed ID: 33481339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-operative radiomics model for prognostication in resectable pancreatic adenocarcinoma with external validation.
    Healy GM; Salinas-Miranda E; Jain R; Dong X; Deniffel D; Borgida A; Hosni A; Ryan DT; Njeze N; McGuire A; Conlon KC; Dodd JD; Ryan ER; Grant RC; Gallinger S; Haider MA
    Eur Radiol; 2022 Apr; 32(4):2492-2505. PubMed ID: 34757450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of intrapancreatic neural density in cancer tissue predicts poorer outcome in pancreatic ductal carcinoma.
    Iwasaki T; Hiraoka N; Ino Y; Nakajima K; Kishi Y; Nara S; Esaki M; Shimada K; Katai H
    Cancer Sci; 2019 Apr; 110(4):1491-1502. PubMed ID: 30776178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advancing glaucoma detection with convolutional neural networks: a paradigm shift in ophthalmology.
    Haja SA; Mahadevappa V
    Rom J Ophthalmol; 2023; 67(3):222-237. PubMed ID: 37876506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.
    Liu E; Zhang ZZ; Cheng X; Liu X; Cheng L
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):50. PubMed ID: 32241274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.